Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 421906, 6 pages
http://dx.doi.org/10.1155/2014/421906
Research Article

Immunophenotypes and Immune Markers Associated with Acute Promyelocytic Leukemia Prognosis

1Hematology Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2Hematology Department, Mianyang Center Hospital, Mianyang 621000, China

Received 5 February 2014; Revised 8 May 2014; Accepted 30 May 2014; Published 19 June 2014

Academic Editor: Mariann Harangi

Copyright © 2014 Fang Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. I. Ahmad, H. Akl, M. E. Hashem, and T. A. M. Elgohary, “The biological characteristics of adult CD34+ acute promyelocytic leukemia,” Medical Oncology, vol. 29, no. 2, pp. 1119–1126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Albano, A. Mestice, A. Pannunzio et al., “The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34- CD2- hypergranular (M3) and microgranular (M3v) phenotypes,” Haematologica, vol. 91, no. 3, pp. 311–316, 2006. View at Google Scholar · View at Scopus
  3. K. Kaito, T. Katayama, H. Masuoka et al., “CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis,” Clinical and Laboratory Haematology, vol. 27, no. 5, pp. 307–311, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Montesinos, C. Rayón, E. Vellenga et al., “Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens,” Blood, vol. 117, no. 6, pp. 1799–1805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Yu and W. T. Zheng, 2010. View at Publisher · View at Google Scholar
  6. P. Lin, S. Hao, L. J. Medeiros et al., “Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARα transcripts and poorer prognosis,” American Journal of Clinical Pathology, vol. 121, no. 3, pp. 402–407, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Gorczyca, “Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping,” Polish Journal of Pathology, vol. 63, no. 1, pp. 8–17, 2012. View at Google Scholar · View at Scopus
  8. H. Y. Dong, J. X. Kung, V. Bhardwaj, and J. McGill, “Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities,” American Journal of Clinical Pathology, vol. 135, no. 1, pp. 76–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Liu, Y. Chen, J. Li, and S.-H. Zhang, “Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia,” Journal of Experimental Hematology, vol. 20, no. 4, pp. 806–811, 2012. View at Google Scholar · View at Scopus
  10. J. Y. Liang, D. P. Wu, Y. J. Liu et al., “The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases,” Zhonghua nei ke za zhi, vol. 47, no. 5, pp. 389–392, 2008. View at Google Scholar · View at Scopus
  11. C. H. Dunphy and W. Tang, “The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 5, pp. 748–754, 2007. View at Google Scholar · View at Scopus
  12. Y. R. Liu, H. H. Zhu, G. R. Ruan et al., “NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes,” Leukemia Research, vol. 37, no. 7, pp. 737–741, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Z. Wang, Y. Z. Qin, B. Jiang et al., “Relationship of immunophenotypic features with minimal residual disease detection and gene types in 221 cases of acute promyelocytic leukemia,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 17, no. 2, pp. 271–276, 2009. View at Google Scholar · View at Scopus
  14. Y. R. Liu, Y. Z. Wang, S. S. Chen et al., “Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia,” Zhonghua Xue Ye Xue Za Zhi, vol. 28, no. 11, pp. 731–736, 2007. View at Google Scholar · View at Scopus
  15. M. Breccia, G. Avvisati, R. Latagliata et al., “Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features,” Leukemia, vol. 21, no. 1, pp. 79–83, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Lou, W. Qian, H. Meng et al., “High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia,” Leukemia Research, vol. 37, no. 1, pp. 37–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Lou, S. Suo, H. Tong et al., “Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy,” Leukemia Research, vol. 37, no. 11, pp. 1451–1456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Schnittger, U. Bacher, C. Haferlach, W. Kern, T. Alpermann, and T. Haferlach, “Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA,” Haematologica, vol. 96, no. 12, pp. 1799–1807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Nowak, M. Klaumuenzer, B. Hanfstein et al., “SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3,” Genes Chromosomes and Cancer, vol. 51, no. 8, pp. 756–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Yin, A. N. Sun, X. P. Tian et al., “Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia,” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 21, no. 1, pp. 39–44, 2013. View at Google Scholar